Morbidly obese | Obese | Overweight | Normal | Underweight | p-value | |
Subjects | 22 (2.0) | 203 (18.9) | 335 (31.1) | 473 (43.8) | 46 (4.3) | |
Female | 31.8 | 39.9 | 50.8 | 52.2 | 78.3 | <0.0001* |
Age years | 62 (46–78) | 66 (52–76) | 68 (56–78) | 66 (45–78) | 58.5 (39–70) | 0.009* |
Duration of admission days | 8 (4–11) | 5 (3–11) | 5 (3–13) | 5 (2–11) | 8 (3–13) | 0.3 |
Congestive cardiac failure | 31.8 | 18.7 | 22.1 | 18.0 | 17.4 | 0.4 |
Cerebrovascular disease | 13.6 | 14.3 | 11.6 | 10.4 | 10.9 | 0.7 |
Diabetes mellitus | 13.6 | 14.3 | 11.1 | 7.8 | 6.5 | 0.1 |
Chronic renal failure | 4.6 | 7.9 | 6.6 | 6.1 | 2.2 | 0.7 |
Chronic liver disease | 9.1 | 3.9 | 4.2 | 5.7 | 6.5 | 0.7 |
COPD | 27.3 | 27.1 | 29.3 | 18.2 | 15.2 | 0.002* |
Current smokers | 18.2 | 35.0 | 36.7 | 32.0 | 39.1 | 0.3 |
Ex-smokers | 45.5 | 23.2 | 21.8 | 21.6 | 10.9 | 0.03* |
Statin use | 45.5 | 28.6 | 29.3 | 25.0 | 21.7 | 0.2 |
Data presented as n (%), median (interquartile range) or %, unless otherwise stated. COPD: chronic obstructive pulmonary disease. *: p<0.05.